Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pittion

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in FranceC Lebrun, M Debouverie, S Jeannin, et al.
Neurology|January 4, 2007
More severe disability of North Africans vs Europeans with multiple sclerosis in FranceM Debouverie, C Lebrun, S Jeannin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2004
Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosisM Debouverie, N Vandenberghe, S P Morrissey, et al.
European Journal of Neurology|July 12, 2018
Clinical follow-up of 411 patients with relapsing and progressive multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real-life cohort studyN Chartier, J Epstein, M Soudant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2007
Primary progressive multiple sclerosis: a comparative study of the diagnostic criteriaJ de Seze, M Debouverie, N Waucquier, et al.
Revue Neurologique|September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteriaJ Ciron, A Gueguen, A Al Khedr, et al.
European Journal of Neurology|November 1, 2008
Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective studyJ Gil, B Funalot, A Verschueren, et al.
Journal of Neurology|May 2, 2015
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric studyA Siri, Clarisse Carra-Dalliere, X Ayrignac, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
European Journal of Neurology|August 2, 2025
Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS StudyP Corcia, D Erazo, M D M Amador, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in FranceC Lebrun, M Debouverie, S Jeannin, et al.
Neurology|January 4, 2007
More severe disability of North Africans vs Europeans with multiple sclerosis in FranceM Debouverie, C Lebrun, S Jeannin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2004
Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosisM Debouverie, N Vandenberghe, S P Morrissey, et al.
European Journal of Neurology|July 12, 2018
Clinical follow-up of 411 patients with relapsing and progressive multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real-life cohort studyN Chartier, J Epstein, M Soudant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2007
Primary progressive multiple sclerosis: a comparative study of the diagnostic criteriaJ de Seze, M Debouverie, N Waucquier, et al.
Revue Neurologique|September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteriaJ Ciron, A Gueguen, A Al Khedr, et al.
European Journal of Neurology|November 1, 2008
Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective studyJ Gil, B Funalot, A Verschueren, et al.
Journal of Neurology|May 2, 2015
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric studyA Siri, Clarisse Carra-Dalliere, X Ayrignac, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
European Journal of Neurology|August 2, 2025
Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS StudyP Corcia, D Erazo, M D M Amador, et al.
Pageof 2